{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:53:08Z","timestamp":1781711588246,"version":"3.54.5"},"reference-count":21,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"unspecified","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"President\u2019s Emergency Plan for AIDS Relief","award":["GH001353-01"],"award-info":[{"award-number":["GH001353-01"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2026,5,20]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Uganda, in line with global efforts to eradicate polio by 2026, conducts surveillance for acute flaccid paralysis (AFP) among children &lt;15 years to enable the timely detection of poliovirus. We analysed national AFP surveillance data to characterise case demographics, spatiotemporal patterns and clinical outcomes, and to evaluate surveillance performance and progress towards eradication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective descriptive analysis of routine AFP surveillance data from 2016 to 2023. Variables included timeliness indicators, non-polio AFP (NPAFP) rates, stool adequacy and demographic, clinical, vaccination and laboratory characteristics. Trends were assessed using the Mann-Kendall test, and spatial patterns were illustrated using choropleth maps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 6409 AFP cases were reported, of which 5837 (91.1%) were confirmed as true AFP. The median age was 3 years (IQR: 1\u20137), with most cases occurring in children &lt;5 years (59.3%) and males (57.8%). Timeliness indicators showed that 63% of cases were notified within 7\u2009days, 93.4% were investigated within 48 hours and 76.5% of stool specimens were shipped within 3\u2009days. Stool adequacy was 88.6% and 99.8% of samples arrived in good condition. The NPAFP rate averaged 3.4\/100 000, meeting the \u22653.0 target in 5 of 8 years. Clinically, 90% of cases were community-identified; 91% had fever at onset, 86% showed rapid progression within 3\u2009days and 80% had asymmetrical paralysis. Among cases with vaccination history, 77% had received \u22653\u2009oral polio vaccine doses and 3% were unvaccinated. Of 6405 samples tested, 2% were classified as suspected poliovirus and 0.1% as mixed non-polio enterovirus and poliovirus. Among 823 followed-up cases, 30% had residual paralysis, 1% had died and 0.6% were lost to follow-up. District-level performance was variable and suboptimal, with averages of 63.4% districts achieving the NPAFP rate target, 74.8% stool adequacy and 49% both core indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Uganda\u2019s AFP surveillance system remains largely robust, though improvements in timeliness, regional equity and follow-up are needed to sustain progress towards polio eradication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjph-2025-003590","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:10:22Z","timestamp":1781709022000},"page":"e003590","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Spatiotemporal and clinical characterisation of acute flaccid paralysis in Uganda, 2016\u20132023"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7992-6355","authenticated-orcid":false,"given":"Emmanuel","family":"Okiror Okello","sequence":"first","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Migisha","sequence":"additional","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculate","family":"Ampaire","sequence":"additional","affiliation":[{"name":"Uganda National Expanded Program on Immunization, Republic of Uganda Ministry of Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Nsubuga","sequence":"additional","affiliation":[{"name":"Uganda National Expanded Program on Immunization, Republic of Uganda Ministry of Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Ofori","sequence":"additional","affiliation":[{"name":"Uganda National Expanded Program on Immunization, Republic of Uganda Ministry of Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda S","family":"Nakafeero","sequence":"additional","affiliation":[{"name":"Uganda National Expanded Program on Immunization, Republic of Uganda Ministry of Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Birungi","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Eliku","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tenywa","sequence":"additional","affiliation":[{"name":"World Health Organization Country Office for Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Kisakye","sequence":"additional","affiliation":[{"name":"World Health Organization Country Office for Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildah T","family":"Nansikombi","sequence":"additional","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Bulage","sequence":"additional","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benon","family":"Kwesiga","sequence":"additional","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Riolexus","family":"Ario","sequence":"additional","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2026061708101090000_4.2.e003590.1","unstructured":"WHO_EPI_GEN_98.01_rev.2.pdf. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/64165\/WHO_EPI_GEN_98.01_Rev.2.pdf?sequence=1 [Accessed 3 Mar 2024]."},{"key":"2026061708101090000_4.2.e003590.2","doi-asserted-by":"crossref","unstructured":"Bandyopadhyay AS , Macklin GR . Global Polio Eradication: Progress and Challenges. In: Ahmad SI, editor. Human Viruses: Diseases, Treatments and Vaccines: The New Insights. Cham 2021;629\u201349. doi:10.1007\/978-3-030-71165-8_30","DOI":"10.1007\/978-3-030-71165-8_30"},{"key":"2026061708101090000_4.2.e003590.3","first-page":"1714","article-title":"Polio: a review","volume":"4","author":"Singh","year":"2013","journal-title":"Int J Pharm Sci Res"},{"key":"2026061708101090000_4.2.e003590.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2009.10.002"},{"key":"2026061708101090000_4.2.e003590.5","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.4161\/hv.24847","article-title":"Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV)","volume":"9","author":"Jin","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"2026061708101090000_4.2.e003590.6","unstructured":"Poliomyelitis. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/poliomyelitis [Accessed 23 Nov 2024]."},{"key":"2026061708101090000_4.2.e003590.7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm7341a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks \u2014 Worldwide, January 2023\u2013June 2024","volume":"73","author":"Namageyo-Funa","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026061708101090000_4.2.e003590.8","unstructured":"Uganda in mass polio immunization following outbreak | WHO | Regional Office for Africa, 2024. Available: https:\/\/www.afro.who.int\/news\/uganda-mass-polio-immunization-following-outbreak [Accessed 24 Nov 2024]."},{"key":"2026061708101090000_4.2.e003590.9","unstructured":"Uganda Virus Research Institute . Polio outbreak confirmed in Uganda, Available: https:\/\/www.uvri.go.ug\/news\/polio-outbreak-confirmed-uganda [Accessed 24 Nov 2024]."},{"key":"2026061708101090000_4.2.e003590.10","unstructured":"Immunization Data . WHO Immunization Data portal - Detail Page, Available: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page [Accessed 9 Mar 2026]."},{"key":"2026061708101090000_4.2.e003590.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-14077-w","article-title":"Trends of key surveillance performance indicators of acute flaccid paralysis: a descriptive analysis, Uganda, 2015\u20132020","volume":"22","author":"Amodan","year":"2022","journal-title":"BMC Public Health"},{"key":"2026061708101090000_4.2.e003590.12","unstructured":"Global-afp-guidelines-pre-publiucation-version-2023.pdf. Available: https:\/\/polioeradication.org\/wp-content\/uploads\/2023\/03\/Global-AFP-guidelines-pre-publiucation-version-2023.pdf [Accessed 20 Apr 2024]."},{"key":"2026061708101090000_4.2.e003590.13","unstructured":"Uganda demographics 2023 (population, age, sex, trends) - worldometer. Available: https:\/\/www.worldometers.info\/demographics\/uganda-demographics\/ [Accessed 16 Apr 2024]."},{"key":"2026061708101090000_4.2.e003590.14","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.supp.2017.27.2.10694","article-title":"Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005-2015: progress and challenges","volume":"27","author":"Tegegne","year":"2017","journal-title":"Pan Afr Med J"},{"key":"2026061708101090000_4.2.e003590.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-17141-1","article-title":"Evaluation of the Acute flaccid paralysis surveillance indicators in Zambia from 2015-2021: a retrospective analysis","volume":"23","author":"Bessing","year":"2023","journal-title":"BMC Public Health"},{"key":"2026061708101090000_4.2.e003590.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-11238-1","article-title":"Evaluation of acute flaccid paralysis surveillance indicators in Sokoto state, Nigeria, 2012-2019: a secondary data analysis","volume":"21","author":"Raji","year":"2021","journal-title":"BMC Public Health"},{"key":"2026061708101090000_4.2.e003590.17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.11648\/j.iji.20170501.13","article-title":"Polio Eradication in Bangladesh: Evaluation of AFP Surveillance Indicators, 2011-2015","volume":"5","author":"Redzwan Habib","year":"2017","journal-title":"IJI"},{"key":"2026061708101090000_4.2.e003590.18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-687","article-title":"Evaluation of AFP surveillance indicators in polio-free Ghana, 2009-2013","volume":"14","author":"Odoom","year":"2014","journal-title":"BMC Public Health"},{"key":"2026061708101090000_4.2.e003590.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001494","article-title":"The effects of COVID-19 lockdown measures on health and healthcare services in Uganda","volume":"3","author":"Musoke","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"2026061708101090000_4.2.e003590.20","doi-asserted-by":"crossref","first-page":"35294381","DOI":"10.9745\/GHSP-D-21-00310","article-title":"Maintaining Polio-Free Status in Indonesia During the COVID-19 Pandemic","volume":"10","author":"Azizatunnisa\u2019","year":"2022","journal-title":"Glob Health Sci Pract"},{"key":"2026061708101090000_4.2.e003590.21","first-page":"075","article-title":"Performance of acute flaccid paralysis surveillance system in Zambia: 2000 to 2009-analysis of secondary data","volume":"3","author":"Chirambo","year":"2014","journal-title":"Int J Public Health Epidemiol"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2025-003590","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:10:30Z","timestamp":1781709030000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2025-003590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjph-2025-003590"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2025-003590","relation":{},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}